To the Editor: Recent reports have raised concerns about transmission of pertussis among troops stationed in Afghanistan and indicated lack of data about pertussis in this country (1, 2 (Figure) .
DEWS collects weekly data on 15 epidemic-prone diseases from 129 sentinel sites, mostly provincial and district hospitals, based on surveillance case defi nitions of the World Health Organization. The case defi nition for suspected pertussis is "a person with a cough lasting at least two weeks and having paroxysms of coughing; or inspiratory 'whoop'; or post-tussive vomiting and without other apparent cause." During the study period, 718 cases meeting the surveillance defi nition for suspected pertussis were recorded in weekly reports from patient visits at DEWS sentinel sites.
When a geographic cluster of at least 5 cases of pertussis is suspected in any area, the DEWS team travels to the area and either confi rms that cases meet the clinical defi nition or rejects the outbreak alert. During outbreak response, DEWS personnel record all cases on a linelist (a rough database), collect throat swabs for laboratory culture, treat case-patients and susceptible contacts (infants and pregnant women) with erythromycin, and schedule follow-up vaccination services for the area. During the study period, the team responded to 56 outbreaks of pertussis in the fi eld that involved 2,233 suspected cases and 32 deaths.
Despite diffi cult geographic features and lack of infrastructure, DEWS collected and transported 203 specimens from patients with suspected pertussis to the Central Public Health Laboratory in Kabul where Bordetella pertussis was successfully isolated in bacteriologic culture from 7 (≈3%) of the specimens. This fi nding compares with that of a recent study from Spain in which 7% of specimens were microbiologically confi rmed (4).
In 75% of the outbreak areas, vaccination coverage was <50%, and median age of patients with suspected cases was 4 years. Thus, Afghanistan needs to continue its focus on raising immunization coverage to >90% by administering the primary series of diphtheria-pertussis-tetanus vaccine to infants. This effort will help reduce transmission among infants and young children for whom pertussis is most lethal (5). 
